Plain-English translation of NCT07032389 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a polypill—a single combination pill that contains aspirin, a blood thinner, and a cholesterol-lowering medication—can work as well as or better than taking these same three medications as separate pills. The study involves 1,000 people who have recently had a heart attack and received a stent to open their blocked artery.
Heart attack survivors face a very high risk of another heart attack or serious complications in the first month after the event. Many patients struggle to take multiple medications as prescribed, which can lead to missed doses and worse outcomes. This medication aims to simplify treatment by combining three essential heart-protective drugs into one pill, hoping to make it easier for patients to stay on track and reduce their risk of complications.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to the combination pill group, you will take one pill containing all three medications daily for 12 months. The other group will continue taking these same three medications as separate pills. The study will track your health over the year to see if the combination pill helps prevent another heart attack or other serious heart problems, with regular follow-up visits to monitor your progress.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States